Michael R. McKellar, BA
Advertisement
Articles by Michael R. McKellar, BA
This commentary discusses why antibiotics and the treatment of infectious diseases present a special case for pharmaceutical development, pricing, and appropriate utilization.
Advertisement
Latest Updated Articles
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: April 23rd 2014 | Updated:
- The Economics of Resistant Pathogens and Antibiotic Innovation
Published: March 18th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
France Expands BOT–BAL Immunotherapy Access for Ovarian Cancer and Soft Tissue Sarcoma
3
Detailed Liver Atlas Links Macrophage Activity to MASH Progression
4
Health Equity & Access Weekly Roundup: January 16, 2026
5
